Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring,Diabetes, Obesity and Metabolism

当前位置： X-MOL 学术 › Diabetes Obes. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2021-08-16 , DOI: 10.1111/dom.14527
Lisa Billion ₁ , Sara Charleer ₂ , Laurens Verbraeken ₁ , Mira Sterckx ₁ , Kato Vangelabbeek ₁ , Nathalie De Block ₁ , Charlien Janssen ₂ , Kristof Van Dessel ₁ , Eveline Dirinck ₁ , Frida Peiffer ₁ , Nancy Bolsens ₁ , Chantal Mathieu ₂ , Pieter Gillard ₂ , Christophe De Block ₁

Affiliation

To evaluate the efficacy and safety of switching from traditional mealtime insulins to fast-acting insulin aspart (Fiasp) in a “real-world” clinical practice setting in adult people with type 1 diabetes (PWD1) who were using intermittently scanned or real-time continuous glucose monitoring (isCGM or rtCGM, respectively).

中文翻译：

在现实环境中使用速效门冬胰岛素控制血糖：一项为期 1 年的两中心研究，使用连续血糖监测对 1 型糖尿病患者进行

评估在“真实世界”临床实践环境中，在使用间歇扫描或实时胰岛素治疗的 1 型糖尿病 (PWD1) 成人患者中，从传统餐时胰岛素转换为速效门冬胰岛素 (Fiasp) 的有效性和安全性连续血糖监测（分别为 isCGM 或 rtCGM）。

更新日期：2021-08-16

点击分享查看原文

点击收藏

阅读更多本刊最新论文